preliminary program · 2020-01-13 · cttc head office: 750 west pender street, suite 301,...
TRANSCRIPT
CTTC Head Office: 750 West Pender Street, Suite 301, Vancouver, BC, V6C 2T7 • T: 604-874-4944 F: 604-874-4378 E: [email protected] W: www.cttcanada.org
Preliminary ProgramANNUAL CONFERENCE OF CELL THERAPY TRANSPLANT CANADA
2020
Québec City, QCJUNE 22-25, 2020
CTTC Head Office: 750 West Pender Street, Suite 301, Vancouver, BC, V6C 2T7 • T: 604-874-4944 F: 604-874-4378 E: [email protected] W: www.cttcanada.org
Preliminary Program2020
Québec City, QCJUNE 22-25, 2020
ANNUAL CONFERENCE OF CELL THERAPY TRANSPLANT CANADA 2
PRE-CONFERENCE DAY – MONDAY, JUNE 22, 2019 (DELTA HOTELS QUEBEC)Registration
10:30am – 4:00pm
BMT 101A: HEALTH CARE PROFESSIONALS BMT101B: PATIENTS, FAMILIES, CAREGIVERS*
12:15pm – 1:30pm Lunch
BMT 101A: CONTINUES BMT101B: CONTINUES
4:00pm – 4:30pm Health Break
4:30pm – 7:00pm PATIENT AND CAREGIVER SYMPOSIUM*
7:00pm – 8:00pm PATIENT AND CAREGIVER SYMPOSIUM DINNER
6:00pm – 9:00pm PRESIDENTIAL SYMPOSIUM: EVOLVING NATIONAL STRATEGIES FOR CAR-T
DAY 1 – TUESDAY, JUNE 23, 2020 (QUEBEC CITY CONVENTION CENTRE)
7:00am – 8:45am CORPORATE SYMPOSIUM WITH BREAKFAST
Registration
Speaker Services
9:00am – 12:15pm SESSION 1: HANS MESSNER LECTURESHIP*CHAIR: Donna Wall, MD (TENTATIVE)
Welcome to the Annual Conference – Donna Wall, MD (TENTATIVE)
Hans Messner Lectureship: Allogenic Transplants in MDS and High Risk AML – Nicolaus Kröger, MD
Hans Messner New Investigator Award: Jonathan Rayment, MDCM, MSc, FRCP(C) (TENTATIVE)
10:00am – 10:30am Health Break
Approaches in MDS and AML for Patients Not-Eligible for Transplantation - Julie Bergeron, MD (TENTATIVE)
12:15pm – 1:45pm CORPORATE SYMPOSIUM WITH LUNCH
* simultaneous translations services available
CTTC Head Office: 750 West Pender Street, Suite 301, Vancouver, BC, V6C 2T7 • T: 604-874-4944 F: 604-874-4378 E: [email protected] W: www.cttcanada.org
Preliminary Program2020
Québec City, QCJUNE 22-25, 2020
ANNUAL CONFERENCE OF CELL THERAPY TRANSPLANT CANADA 3
DAY 1 – TUESDAY, JUNE 23, 2020 (QUEBEC CITY CONVENTION CENTRE)
2:00pm – 5:00pm SESSION 2A: SCIENCE* Till & McCulloch Lectureship: Guy Sauvageau, MD
SESSION 2B: LABORATORYAdvanced Cell Therapies and the Role of Canadian CT Labs – Martin Giroux, PhD
SESSION 2C: NURSING* How to Inform and Educate Patients (FR) – Sarah-Judith Breton, RN
SESSION 2D: PHARMACY Transplants for SCID and Other Autoimmune Diseases – Esther Jadusingh, BSc, BScPharm, ACPR
3:00pm – 3:30pm Health Break
SESSION 2A: CONTINUES
Gene Therapy for Immune Deficiency – Donald Kohn, MD
SESSION 2B: CONTINUES
Laboratory Nightmares: Past Incidents and Actions to Prevent Future Occurrences – Jelena Holovati, MLT, PhD, and Mike Halpenny, MLT CliniMACs Procedure: Understanding and Optimizing Cell Recoveries – Nicole Prokopishyn, PhD and Miltenyi Biotec
SESSION 2C: CONTINUES
Pain Management (Dexmedethomidine in Refractory Acute Pain for BMT Patient)Out-Patient Transplant Setting: The Role of the Nurse
SESSION 2D: CONTINUES
Access to New Medication Used in the Treatment of GvHD – Nikki Blosser, BSc, BScPharm, ACPR Outpatient Stem Cell Transplant: the Role of the Pharmacist –Philippe Bouchard, BPharm, MSc, BCOP, & Melanie Trinacty, BPharm, BSc, Lina Ho, BPharm
5:00pm – 6:00pm WELCOME RECEPTION
6:30pm – 8:00pm CORPORATE SYMPOSIUM WITH DINNER
8:00pm – 9:00pm NETWORKING SESSIONS:Nursing Networking Session Pharmacist Networking Session Administrators and Bmt Coordinators Networking Session Laboratory Networking Session Advanced Practitioners Networking Session Bmt Physicians Meeting
* simultaneous translations services available
CTTC Head Office: 750 West Pender Street, Suite 301, Vancouver, BC, V6C 2T7 • T: 604-874-4944 F: 604-874-4378 E: [email protected] W: www.cttcanada.org
Preliminary Program2020
Québec City, QCJUNE 22-25, 2020
ANNUAL CONFERENCE OF CELL THERAPY TRANSPLANT CANADA 4
DAY 2 – WEDNESDAY, JUNE 24, 20207:00am – 8:45am CORPORATE SYMPOSIUM WITH BREAKFAST
Registration
Speaker Services
9:00am – 10:00am SESSION 3: FRED SAUNDERS LECTURESHIP* Fred Saunders Lectureship: Gene Therapy For Hemoglinopathy – Marina Cavazzana, MD
10:00am – 10:15am Health Break
10:15am – 11:15am CTTC ANNUAL GENERAL MEETING
11:30am – 1:00pm CORPORATE SYMPOSIUM WITH LUNCH
1:15pm – 3:15pm
SESSION 4: CAR-T AND THE FUTURE OF CELL THERAPYState of the Nation of CAR-T in Canada – Isabelle Fleury, MD
Advancing Cell Therapies – Cameron Turtle (TENTATIVE)
CAR-NK Cells – Kathy Rezvani (TENTATIVE)
3:15pm – 3:30pm Health Break
3:30pm – 4:30pm POSTER ABSTRACT PRESENTATIONS
4:30pm – 5:30pm ORAL ABSTRACT PRESENTATIONS ORAL ABSTRACT PRESENTATIONS
7:00pm Onwards GALA DINNER SOCIAL: MUSÉE DE LA CIVILIZATION
* simultaneous translations services available
CTTC Head Office: 750 West Pender Street, Suite 301, Vancouver, BC, V6C 2T7 • T: 604-874-4944 F: 604-874-4378 E: [email protected] W: www.cttcanada.org
Preliminary Program2020
Québec City, QCJUNE 22-25, 2020
ANNUAL CONFERENCE OF CELL THERAPY TRANSPLANT CANADA 5
Cell Therapy Transplant Canada (CTTC) is pleased to partner with Héma-Québec for Canadian Innovation Day, hosted by the World Marrow Donor Association (WMDA)
DAY 3- THURSDAY, JUNE 25, 2020: CANADIAN INNOVATION DAYRegistration
Speaker Services
7:00am – 8:45am CORPORATE SYMPOSIUM WITH BREAKFAST
9:00am – 10:15am(Room 200AB)
SESSION 5: FAIR FIGHT FOR ALLIntroduction: Canadian Innovation Day – Jean-Sébastien Delisle, MD, PhD
Swab The World Foundation – Mai Duong & Christiane Rochon First Nations Project (Héma-Québec) – Nadia Baillargeon & Lucie Richard Panel Discussion and Q&A
10:15am – 10:25am Health Break
10:45am – 11:45am
SESSION 6: GENE EDITINGCRISPR – Brief History and Current Application – Sylvain Moineau, PhD Blood Stem Cell Genome Editing: CCR5 – Ellie Haddad, MD (Tentative)
Panel Discussion: Ethical Considerations
11:45am – 12:35pm Lunch
12:35am – 2:20pm (Room 2000A)
ENABLING INNOVATIONCord Blood Expansion UM171: How will it Affect CBU Selection – Sandra Cohen, MD
Haplo Transplantation: ATIR – Denis-Claude Roy, MD (TENTATIVE)
More than Minimally Manipulated T-Cell Immunotherapies – Jean-Sébastien Delisle, MD, PhD
2:20pm – 2:35pm Health Break (Sponsored by Ontime Courier – Héma-Québec/WMDA)
2:35pm – 4:55pm
ENABLING INNOVATIONTransplantation in MS – Harry Atkins, MD CHUM Innovative Projects – Réjean Lapointe, PhD BioCANRx: Canadian CARs – Kevin Hay, MD (TENTATIVE)
Adoptive Transfer of Plasmacytoid Dendritic Cells to Increase GVL Effect – Michel Duval, MD
6:00pm – 9:00pm CTTC OFFSITE NETWORKING EVENT (LE MONASTÈRE DES AUGUSTINES)